Paysign, Inc. short interest in 2023
In 2023, Paysign, Inc.'s disclosed short interest ran from 0.81% of shares outstanding on 13 Jan 2023 to 1.71% on 29 Dec 2023, a change of +0.90 percentage points. The year's high was 1.79% on 29 Sep 2023 and its low 0.49% on 15 Jun 2023, averaging 1.12% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.97 days on 31 Oct 2023. Full history: Paysign, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.81% (13 Jan 2023)
- End of year
- 1.71% (29 Dec 2023)
- Change
- +0.90 pp
- High
- 1.79% (29 Sep 2023)
- Low
- 0.49% (15 Jun 2023)
- Average
- 1.12%
- Highest days to cover
- 11.97 (31 Oct 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.81% | 4.33 | |
| 31 Jan 2023 | 0.53% | 1.83 | |
| 15 Feb 2023 | 0.51% | 1.67 | |
| 28 Feb 2023 | 0.51% | 2.68 | |
| 15 Mar 2023 | 0.55% | 1.95 | |
| 31 Mar 2023 | 0.58% | 1.81 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 0.56% | 1.41 | |
| 28 Apr 2023 | 0.54% | 2.66 | |
| 15 May 2023 | 0.57% | 2.69 | results (8-K), 10-Q filed |
| 31 May 2023 | 0.55% | 1.98 | |
| 15 Jun 2023 | 0.49% | 1.16 | |
| 15 Aug 2023 | 1.74% | 4.41 | results (8-K), 10-Q filed |
| 31 Aug 2023 | 1.72% | 7.92 | |
| 15 Sep 2023 | 1.66% | 5.80 | |
| 29 Sep 2023 | 1.79% | 9.66 | |
| 13 Oct 2023 | 1.73% | 9.15 | |
| 31 Oct 2023 | 1.77% | 11.97 | |
| 15 Nov 2023 | 1.75% | 8.23 | results (8-K), 10-Q filed |
| 30 Nov 2023 | 1.73% | 10.07 | |
| 15 Dec 2023 | 1.75% | 7.56 | |
| 29 Dec 2023 | 1.71% | 7.49 |
See also: Paysign, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.